More price cuts for Philippine drugs postponed for 2010

Thursday, December 17, 2009

More price cuts for drugs postponed for 2010

From abs-cbn Newsbreak 12/16/2009 MANILA, Philippines -Price cuts for new batches of medicines were postponed for 2010 as insufficient manpower and delays in information sourcing stymied the expansion of the coverage of the Cheap Medicines Act.

In the oversight committee hearing at the Senate on Wednesday, officials from the Department of Health (DOH) admitted that the number of drugs covered by the voluntary price reduction and the maximum retail price stays at 21.

There are 16 other medicines subject to government-mediated 10% to 15% price decrease since President Arroyo signed the Cheaper Medicines Act in August.

Five common drugs have been initially placed under maximum retail price (MRP), or a mandatory 50% price cut. These drugs include the Amlodipine for hypertension, Atorvastatin for anti-cholesterol, Azithromycin as antibiotic/antibacterial, Cytarabine and Doxorubicin for anti-neoplastics/anti-cancer.

Compliance check

Nonetheless, the DOH reported that prices of some medicines not in the first list have been slashed. The officials cited Losartan, a drug against hypertension.

The DOH and DTI also entered into agreements with two companies to sell insulin preparations for only P525 to P550 per vial.

Insulin products are normally priced at P1,400 per vial.  Continue reading here

1 comment

Drugs, is what kills humanity. Just recently, Obama's daughter went to the festival in a t-shirt against Smoking, even though she at the last festival was seen for Smoking weed

September 5, 2016 at 5:10 AM

Post a Comment